1. Astegolimab or Efmarodocokin Alfa in Patients With Severe COVID-19 Pneumonia: A Randomized, Phase 2 Trial*. Issue 1 (14th November 2022) Authors: Waters, Michael; McKinnell, James A.; Kalil, Andre C.; Martin, Greg S.; Buchman, Timothy G.; Theess, Wiebke; Yang, Xiaoying; Lekkerkerker, Annemarie N.; Staton, Tracy; Rosenberger, Carrie M.; Pappu, Rajita; Wang, Yehong; Zhang, Wenhui; Brooks, Logan; Cheung, Dorothy; Galanter, Joshua; Chen, Huber... Other Names: Meena Nikhil author non-byline.; Waters Michael author non-byline.; Overcash Jeffrey author non-byline.; Mealey Forest author non-byline.; McKinnell James author non-byline.; Douglas Ivor author non-byline.; Buck Theresa author non-byline.; Mendez-Mulet Luis author non-byline.; Boyce Paul author ... Journal: Critical care medicine Issue: Volume 51:Issue 1(2023) Page Start: 103 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗